Form 8-K - Current report:
SEC Accession No. 0000950170-24-052121
Filing Date
2024-05-02
Accepted
2024-05-02 16:12:37
Documents
12
Period of Report
2024-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bmea-20240502.htm   iXBRL 8-K 37915
2 EX-99.1 bmea-ex99_1.htm EX-99.1 112186
  Complete submission text file 0000950170-24-052121.txt   274730

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bmea-20240502.xsd EX-101.SCH 24868
15 EXTRACTED XBRL INSTANCE DOCUMENT bmea-20240502_htm.xml XML 4704
Mailing Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063
Business Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Filer) CIK: 0001840439 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40335 | Film No.: 24908382
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)